Kadowaki, T., Nishida, T., & Kaku, K. (2010). 28‐week, randomized, multicenter, open‐label, parallel‐group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice‐daily injections vs twice‐daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes. Blackwell Publishing Ltd.
Chicago ZitierstilKadowaki, Takashi, Tomoyuki Nishida, und Kohei Kaku. 28‐week, Randomized, Multicenter, Open‐label, Parallel‐group Phase III Trial to Investigate the Efficacy and Safety of Biphasic Insulin Aspart 70 Thrice‐daily Injections Vs Twice‐daily Injections of Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes. Blackwell Publishing Ltd, 2010.
MLA ZitierstilKadowaki, Takashi, Tomoyuki Nishida, und Kohei Kaku. 28‐week, Randomized, Multicenter, Open‐label, Parallel‐group Phase III Trial to Investigate the Efficacy and Safety of Biphasic Insulin Aspart 70 Thrice‐daily Injections Vs Twice‐daily Injections of Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes. Blackwell Publishing Ltd, 2010.